特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
939177

風邪・インフルエンザ治療薬:世界市場の展望(2018年~2027年)

Cold & Flu Drugs - Global Market Outlook (2018-2027)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 145 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
風邪・インフルエンザ治療薬:世界市場の展望(2018年~2027年)
出版日: 2020年05月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 145 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の風邪・インフルエンザ治療薬市場は、2018年に127億8,000万米ドルとなりました。同市場は、予測期間中に8.4%のCAGRで成長する見通しで、2027年には264億米ドルに達すると予測されています。市場成長を促進する主な要因には、暴飲暴食の増加、ジャンクフードの消費、定期的な運動不足、ストレスの増加などが挙げられます。

当レポートは世界の風邪・インフルエンザ治療薬市場について調査しており、市場機会や動向、成長および抑制要因、製品タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • イントロダクション
  • 成長要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • 用途分析
  • 新興市場
  • 新型コロナウイルス感染症の影響

第4章 ポーターのファイブフォース分析

第5章 世界市場: 製品タイプ

  • イントロダクション
  • 充血除去剤
  • 抗生物質
  • 抗ヒスタミン剤
  • 去痰薬
  • 気管支拡張薬

第6章 世界市場:用途別

  • イントロダクション
  • 処方箋
  • 市販(OTC)薬

第7章 世界市場: 地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ

第8章 主な発展

  • 契約、提携、協業、合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の主な戦略

第9章 企業プロファイル

  • Bayer
  • AstraZeneca
  • Procter and Gamble
  • Reckitt Benckiser Group
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novartis
  • Sun Pharmaceutical Industries
  • Pfizer
  • Prestige Brands Holdings
図表

List of Tables

  • Table 1 Global Cold & Flu Drugs Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 3 Global Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 4 Global Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 5 Global Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 6 Global Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 7 Global Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 8 Global Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 9 Global Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 10 Global Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 11 North America Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 12 North America Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 13 North America Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 14 North America Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 15 North America Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 16 North America Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 17 North America Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 18 North America Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 19 North America Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 20 North America Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 21 Europe Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 22 Europe Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 23 Europe Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 24 Europe Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 25 Europe Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 26 Europe Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 27 Europe Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 28 Europe Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 29 Europe Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 30 Europe Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 31 Asia Pacific Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 32 Asia Pacific Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 33 Asia Pacific Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 34 Asia Pacific Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 35 Asia Pacific Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 36 Asia Pacific Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 37 Asia Pacific Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 38 Asia Pacific Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 39 Asia Pacific Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 40 Asia Pacific Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 41 South America Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 42 South America Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 43 South America Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 44 South America Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 45 South America Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 46 South America Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 47 South America Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 48 South America Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 49 South America Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 50 South America Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 51 Middle East & Africa Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 52 Middle East & Africa Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 53 Middle East & Africa Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 54 Middle East & Africa Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 55 Middle East & Africa Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 56 Middle East & Africa Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 57 Middle East & Africa Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 58 Middle East & Africa Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 59 Middle East & Africa Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 60 Middle East & Africa Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
目次

According to Stratistics MRC, the Global Cold & Flu Drugs Market is accounted for $12.78 billion in 2018 and is expected to reach $26.40 billion by 2027 growing at a CAGR of 8.4% during the forecast period. Some of the key factors propelling the market growth include increasing cases of obesity all over the globe, increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress. However, cold & flu drugs may causes allergic reaction is likely to hamper the market.

Cold and Flu is a most common diseases infect to human. People think cold and flu is not major but sometimes it may be harmful for those. Due this awareness Cold and Flu Drugs is on demand. Cold and Flu Drugs are easily available in any medical store and less expense.

By application, over the counter (OTC) drugs segment is poised to witness lucrative growth over the forecast timeframe, due to increasing prevalence of digestion disorders, common flu, and cold. Over-the-counter (OTC) drugs also called as non-prescription drugs are medicines that do not require prescription from healthcare professionals for selling it to consumers. These drugs are available at pharmacies, supermarkets, general stores, and gas stations across several countries. However, these drugs are solely authorized for dispense by pharmacists, after confirming age, identity, and patient's knowledge regarding the product and its utility.

On the basis of geography, Asia Pacific region is projected to have considerable market growh during the forecast period, owing to growing patient awareness regarding consumption of OTC drugs, leading to self-medication practices. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.

Some of the key players in cold & flu drugs market include Bayer, AstraZeneca, Procter and Gamble, Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Sun Pharmaceutical Industries, Pfizer, and Prestige Brands Holdings.

Product Types Covered:

  • Decongestants
  • Antibiotics
  • Antihistamines
  • Expectorants
  • Bronchodilators

Applications Covered:

  • Rx Drugs
  • Over the Counter (OTC) Drugs

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cold & Flu Drugs Market, By Product Type

  • 5.1 Introduction
  • 5.2 Decongestants
  • 5.3 Antibiotics
  • 5.4 Antihistamines
  • 5.5 Expectorants
  • 5.6 Bronchodilators

6 Global Cold & Flu Drugs Market, By Application

  • 6.1 Introduction
  • 6.2 Rx Drugs
  • 6.3 Over the Counter (OTC) Drugs

7 Global Cold & Flu Drugs Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Bayer
  • 9.2 AstraZeneca
  • 9.3 Procter and Gamble
  • 9.4 Reckitt Benckiser Group
  • 9.5 Johnson & Johnson
  • 9.6 GlaxoSmithKline
  • 9.7 Novartis
  • 9.8 Sun Pharmaceutical Industries
  • 9.9 Pfizer
  • 9.10 Prestige Brands Holdings
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.